Concepedia

Yuta Takagaki

YT

10

Publications

886

Citations

10

H-Index

2018

Active since

Affiliations

Kanazawa Medical University(Current)

Shimane University

Yuta Takagaki is an author at Kanazawa Medical University specializing in metabolic syndrome, chronic kidney disease, and diabetes.

ORCID

Top concepts

Publications per year

2018–2021

10

Publications

10

Renal protective effects of empagliflozin via inhibition of EMT and aberrant glycolysis in proximal tubules

Jinpeng Li, Haijie Liu, Susumu Takagi et al. · JCI Insight · 2020 · 231 citations · Full text

, , +22

Inhibition of Dipeptidyl Peptidase-4 Accelerates Epithelial–Mesenchymal Transition and Breast Cancer Metastasis via the CXCL12/CXCR4/mTOR Axis

Fan Yang, Yuta Takagaki, Yasuo Yoshitomi et al. · Cancer Research · 2018 · 133 citations

Ipragliflozin improves mitochondrial abnormalities in renal tubules induced by a high‐fat diet

Susumu Takagi, Jinpeng Li, Yuta Takagaki et al. · Journal of Diabetes Investigation · 2018 · 122 citations · Full text

Endothelial autophagy deficiency induces IL6 - dependent endothelial mesenchymal transition and organ fibrosis

Yuta Takagaki, Seon Myeong Lee, Zha Dongqing et al. · Autophagy · 2020 · 114 citations · Full text

The PKM2 activator TEPP‐46 suppresses kidney fibrosis via inhibition of the EMT program and aberrant glycolysis associated with suppression of HIF‐1α accumulation

Haijie Liu, Yuta Takagaki, Asako Kumagai et al. · Journal of Diabetes Investigation · 2020 · 100 citations · Full text

Rows per page

1–5 of 10